#vertical integration biotech

Discover 2 curated intelligence briefings related to this specific topic.

Next-Gen Ligation Dictates ADC Industrial Viability
Science & Nature

Next-Gen Ligation Dictates ADC Industrial Viability

Industrial scale-up of Antibody-Drug Conjugates (ADCs) now demands a transition from random conjugation to site-specific bioorthogonal ligation. By integrating high-yield protein secretion platforms and multifunctional payloads like STING antagonists, manufacturers can stabilize the drug-to-antibody ratio (DAR) for complex bispecific architectures.

Read Analysis
Industrializing the Living Cell Requires Hard Engineering
Science & Nature

Industrializing the Living Cell Requires Hard Engineering

Scaling synthetic biology is not a matter of larger vats, but of systemic integration. From the FDA's hub-and-spoke regulatory shifts to the vertical integration seen in Neko Health's $700M expansion, industrialization requires a precise alignment of automation, AI-driven variability modeling, and strategic market phasing.

Read Analysis